title: [A favorable response to the somatostatin analog SMS 201-995 in a patient with the carcinoid syndrome].
abstract: A patient with carcinoid syndrome was treated with the somatostatin analogue (SMS 201-995). The drug significantly improved the symptoms of the patient, flushing and diarrhea, and reduced urinary excretion of 5-hydroxyindole acetic acid. However, hepatic metastases remained unchanged. Clinical or biochemical adverse effects were not present during the treatment period.
authors.affiliation: Servicio de Medicina Digestiva, Hospital La Fe, Valencia.
authors.forename: A
authors.initials: A
authors.lastname: Del Val
authors.forename: J
authors.initials: J
authors.lastname: Ponce
authors.forename: A
authors.initials: A
authors.lastname: Talens
authors.forename: L
authors.initials: L
authors.lastname: Martí-Bonmati
authors.forename: V
authors.initials: V
authors.lastname: Garrigues
authors.forename: J
authors.initials: J
authors.lastname: Berenguer
mesh_terms: D000328:Adult; D004341:Drug Evaluation; D004361:Drug Tolerance; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D009382:Neoplasms, Unknown Primary / Q000188:drug therapy; D015282:Octreotide / Q000009:adverse effects / Q000627:therapeutic use*; D012074:Remission Induction
chemical_list: D015282:Octreotide
vernacular_title: Respuesta favorable al análogo de la somatostatina SMS 201-995 en un paciente con síndrome carcinoide.